- Home
- AIRT vs FBRX Comparison
AIRT vs FBRX Comparison
Compare AIRT & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | FBRX |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 253.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRT | FBRX |
|---|---|---|
| Price | $20.01 | $21.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 1.6K | ★ 113.8K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $279,216,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.56 | $4.90 |
| 52 Week High | $26.70 | $25.97 |
Technical Indicators
Market Signals| Indicator | AIRT | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 64.32 |
| Support Level | $18.42 | $18.85 |
| Resistance Level | $19.65 | $21.45 |
| Average True Range (ATR) | 0.41 | 2.00 |
| MACD | -0.02 | 0.14 |
| Stochastic Oscillator | 48.12 | 66.30 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).